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Abstract
Introduction:People with visual impairment (VI) have loss of vision that causes impact on their daily living activities. Synonymous of
VI are blindness, low vision, subnormal vision, visual incapacity, although there are peculiarities among them. The autonomic nervous
system (ANS) provides the body with dynamic adaptation, moment by moment, according to changes in the internal and/or external
body environment. As VI is an adverse condition, it is expected to be associated with changes in systemic autonomic activity, such as
heart rate (HR) variability.
Objective: To analyze the blindness stress by monitoring the activity of the ANS in the heart in subjects submitted acutely to low
vision and also in subjects with chronic visual deficiency.
Method: This is a randomized trial experimental study. In this clinical trial, initially, patients will undergo an ophthalmologic medical
evaluation, along with monitoring of HR and systolic blood pressure /diastolic blood pressure. Volunteers with normal vision (Group i);
and people with VI (Group ii) will be evaluated, all of them inhabitants of Rio Branco City, capital of Acre State, Brazilian Amazon. The
intervention will consist of simulating blindness by sealing both eyes of each participant with good eyesight, using a sleep mask and
allowing maximum occlusion for 45 minutes, split into 3 periods of 15 minutes each. Still blindfolded, participants will be requested to
perform different tasks as walking, serve themselves water and/or cookies, and engaging in playful-pedagogical activity. Identical
procedure will be done with the group with VI. The HR will be recorded by the Polar RS800 HR monitor. All findings with a value of
P< .05 will be considered statistically significant. As a risk measure the odds ratio will be calculated, adjusted, and not adjusted with
their respective 95% confidence intervals. The odds ratio=1 of lowest risk for the outcome of interest will be considered as the base
category for each independent variable.
Ethics and dissemination: This study will be carried out in accordance with the guidelines that regulate human research in
Resolution No. 466/12 of the National Health Council. We obtained the approval of the Research Ethics Committee of the ABC
Medical School/Faculdade de Medicina do ABC, with CAAE: 73945017.0.0000.0082, and Opinion No. 2,275,101. All individuals
who agreed to participate in the study will sign the free and informed consent form (FICF). The FICF is also available in audio and Braille
versions. The results will be disseminated through peer-reviewed journal articles and conferences. This study is registered in the
Brazilian Registry of Clinical Trials under the number RBR-9sm9dp.
Abbreviations: ANS= autonomic nervous system, BP= blood pressure, DBP= diastolic blood pressure, HD= hemodialysis, HR
= heart rate, HRV = heart rate variability, R-R intervals = intervals between consecutive heart beats, VI = visual impairment.
Keywords: autonomic nervous system, blindness, heart rate, visual impairment
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People with visual impairment (VI) have loss of vision that causes
impact on their daily living activities. Synonymous of VI are:
blindness, low vision, subnormal vision, and visual incapacity,
although there are peculiarities among them.[1]
Theprevalenceandcause ofblindness varywith regionand time.
Overall, in 1990 there were about 31.8 million blind people and
172million peoplewithVI. In 2010, the numbers increased to 32.4
million blind people and 191 million people with disabilities.[1]
The autonomic nervous system (ANS), through the sympathetic
and parasympathetic divisions, provide dynamic adaptations in
the body, moment to moment, according to internal changes and/
or depending on alterations on the external environment.[2] Since
VI is an adverse condition, association with changes in systemic
autonomic activity, such as heart rate variability (HRV), blood
pressure (BP), changes in body temperature, and electrical
conductivity of the skin, among others, is expected.[3]
Since cardiac function is regulated by the interaction of the
sympathetic and parasympathetic branches of the ANS,HRV can
be an important tool to investigate the oscillations in the intervals
between consecutive heart beats (R-R intervals), which are
related to the influences of the ANS on the sinus node, the natural
heart pacemaker. It is a noninvasive technique, whose analysis
can be performed using a linear method at time and frequency
domains, or by nonlinear methods in the chaos domain[4]
Time domain methods use mathematically simple techniques
to measure the variability present in the R-R intervals by
calculating their mean and the variations of the standard
deviation of heart rate (HR) over time.[5,6] While frequency
domain methods use spectral analysis that allows the decompo-
sition of HR variation at a given time into its fundamental
oscillatory components, that is, the time series is decomposed into
different frequency components.[7]
In nonlinear analysis, the chaos theory approach considers
systems, dynamic, deterministic, governed by nonlinear equa-
tions, and sensitive to initial conditions.[8] This form of analysis
may more adequately reflect changes in the autonomic modula-
tion of biological systems, as evidence indicates that the
mechanisms involved in cardiovascular regulation probably
interact nonlinearly with each other.[9]
It is important to consider whether VI affects the cognitive and
attitudes of the patients, as well as the clinical variations of the
cardiac autonomic modulation, either if the low vision is acutely
presented to the subject or chronically present, after a longerperiod
of disability. In some diseases, not involving the visual apparatus,
this interference in autonomic modulation may be reflected by a
reduction in HRV, which has sometimes been suggestive of an
indication of worse prognosis in cardiovascular diseases[8,10] and
related to the appearance of arrhythmias and sudden death.[11,12]
On the contrary, limited literature has been published about
this subject, namely visual deficiency vs HRV, which strengthens
and justifies the accomplishment of this research. Thereby, this
study focused to analyze the blindness stress by monitoring the
activity of the ANS in the heart in subjects submitted acutely to
low vision and also in subjects with chronic visual deficiency.
2. Materials and methods
2.1. Type, location, and population of the study
This study protocol follows the items of the Standard Protocol for
Randomized Trials. It is an experimental study, specifically a
randomized clinical trial on the autonomic HR modulation
response, in which 50 volunteers with normal vision (Group i)
and 50 individuals with visual deficiency (Group ii) have attended
the Pedagogical Service of Support Center for People with VI
(Fig. 1).
2.2. Subject eligibility criteria
People of both sexes, over 18 years old, with good visual acuity,
healthy, and who do not need correctional lenses, such as glasses,
will be eligible to form Group i. The Group ii will be constituted
Group i
- Both sexes;
- Older than 18 
years;
- Good visual 
acuity;
- Healthy;
- Do not use  
corrective lenses.
- With no visual 
impairment: 
those who present 
visual acuity 
better than 20/30 
in at least one eye.
Group ii
- Older than 18 years;
- Both sexes;
- People with visual 
impairment or 
blindness, in good 
general health, 
without other physical 
and mental disabilities
- With Visual 
impairment: those 
with visual acuity less 
than 20/70 and greater 
than 20/400 in the best 
eye; 
- Blind: Those with 
visual acuity worse 
than 20/400
Figure 1. Subject eligibility criteria.
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by people, also over 18 years of age, both genders, with VI or
blindness, with good general health, and without other physical
and mental disabilities. In this context, those who present visual
acuity better than 20/30 in at least 1 eye will be admitted as
participant of Group i, without VI. A 2nd group with VI (Group
ii), will include individuals with visual acuity less than 20/70 and
greater than 20/400 in the best eye; as blind people with visual
acuity worse than 20/400, finger counts at 1m and with lack of
light perception in the best eye, according to criteria of the World
Health Organization.[13]
Individuals who do not comply the clinical criteria described or
refused to participate or continue in the survey will be excluded.
Volunteers will be instructed for not drinking alcohol and/or
caffeine within 24hours prior to the intervention.
2.3. Expected risks
Risks are minimal. If patients feel uncomfortable during
evaluation sessions, they can withdraw the research at any time.
2.4. Expected benefits
Provide scientific information from comparative assessment
between the groups, through the analysis of HRV during the
proposed tasks.
Demonstrate ANS reactions in different situations with
individuals without visual disorder and individuals with VI.
2.5. Intervention
Liao et al[14] studied 2 groups with 20 patients each, performing a
30-minute exercise program of electric bicycle and a 5-minute
cooling during the treatment of hemodialysis (HD) in the renal
unit. The exercise was performed under supervision of a physician
and a nurse specialized in rehabilitation. This protocol was
adapted to be carried out with 2 groups of 50 people each.We also
modified the time for the accomplishment of activities, they will be
developed in 45 minutes, split in 3 periods of 15minutes each.
Times were defined as rest, intervention, and recovery. The
executionwill be supervised by a researcher, an ophthalmologist, a
professional physical educator, a nurse, a student, and a secretary.
Marques et al[15] measured exercise intensity by using the Borg
rating of perceived exertion scale. In our study, patients will
perform activities without load prescription. In the study by
Raimundo et al,[16] the subjects walked on a treadmill for aerobic
exercises split into 5minutes of warm-up and 25minutes of
exercise, reaching 50% to 70% of their maximal HR. Morais
et al[17] used in its protocol in patients in HD, aerobic exercise of
cyclical movements of the lower limbs with 45% to 60% of
intensity of its HR maximum.
Morais et al[17] performed aerobic exercises with a total time of
30minutes, 3 times a week for 3 months. The subjects were
instructed to remain with arms extended normally in the
extension of the chair next to the body, accommodated in the
best possible way. The lower limbs that were the most active part
in the exercise performed a constant rotation (pedals) throughout
the aerobic exercise in the mechanical cycle ergometer for lower
limbs. Patients will be encouraged to increase their intensity
according to individual capacity, respecting the principle of
biological individuality.
In our case, in the intervention phase, the activities performed
will be sensorial, by handling objects, the motor part consists in
walking blindfolded for 5minutes through the corridors and
clinic rooms, and at the end cognitive activities will be performed
with pedagogic games. The protocol was modified so that
individuals from both groups will be monitored for 45minutes,
divided into 3 times of 15minutes each. Each phase will be
monitored for its HRV and will be called rest-intervention-
recovery. The phase with greater intensity will be the interven-
tion, because the time of this phase will be divided in 3 periods of
5minutes each. In each subphase of 5minutes, the individuals will
perform 3 different activities. The 1st task will be to serve glasses
with water and food. Then, the next task will be locomotion
through the clinic areas and the last stage activities will be to
assembly pedagogical toys (Figs. 2 and 3).
2.6. Team work
The research team will include 2 ophthalmologists, 2 physical
educators, a nurse, 2 medical, nurse and physical education
academics, and 2 secretaries from the Rio Branco Eye Health
Center (Fig. 4).
2.7. Data collection instruments
First phase: A sheet will be used to collect personal and
sociodemographic data, complemented with clinical data
according to the execution of medical examinations and
interventions in the study participants.
Initially, it is intended to form the Group ii by searching people
with VI from the Pedagogical of Support Center CAP-AC
database, a public institution that exclusively provides socio-
educational support services to low vision patients and the
Centro de Saude Ocular (CSO), which is a private clinic of
ophthalmologic care in Rio Branco City. Individuals for Group i
those without VI who have good visual acuity will be invited from
the CSO, seeking to match them as closely as possible with Group
ii, regarding gender, age, occupation, etc.
After initial selection, volunteers will be submitted to routine
clinical-ophthalmological examination, where aspects of general
health will be investigated, as well as medication that may
interfere with ANS, among others. Other aspects of eye health,
such as visual acuity, corrective lenses, and history of ophthalmic
surgery also will be evaluated.
Clinical and ophthalmological examinations that will indicate
the study independent variables will be performed at the CSO,
which has qualified human resources and medical equipment for
anamnesis, visual acuity measurement, ocular pressure measure-
ment, among others, with no costs for participants.
Second phase: In this phase, data of HRVwill be collected. The
protocolwill be the same for both groups (Group i andGroup ii). It
will be divided in 3moments of 15minutes each: rest-intervention-
recovery. After taking anthropometricmeasures, the participant of
Group i will be given a brief rest in seated position, in a quiet
environment, then the systolic, diastolic, andmeanBP andHRwill
bemeasured todefinea baseline condition (rest phase). Then, in the
2nd step or intervention phase, both eyes of the participant will be
blindfolded with a sleeping mask that provides maximum
occlusion (Fig. 5), remaining with vigilance and companionship.
Intervention phase will be subdivided into 3 times of 5minutes
each to perform 3 different tasks, as follows:
1. First task, the participant still blindfolded will be asked to
perform seizure tasks, serving water and/or biscuits on a tray,
sitting with the objects placed at the table in front of him.
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2. Second task is for motor locomotion, such as walking through
clinic areas between corridors and rooms.
3. Third task will be ludic-pedagogical activities as fitting of
different objects according to their mold like a puzzle (Fig. 6).
At each stage of 5-minute intervention activities, the patient
will be monitored for their systolic and diastolic HR and level of
blood glucose.
In the 3rd phase called recovery with a duration of 15minutes,
the participants will sit relaxed and resting, continuing tomonitor
the collection of autonomic cardiac activity through the HRV.
Participants of Group ii, after verifying their anthropometric
measures, will be submitted to the same protocol of Group i.
Measurements include systolic blood pressure, DBP, mean
arterial pressure, HR, and blood glucose level.
EVALUATION OF ANTHROPOMETRIC MEASURES
WEIGHT HEIGHT
OPHTHALMOLOGICAL EXAMS
USE OF MEDICATION EYE HEALTH 
PHASE 1
SOCIO-DEMOGRAPHIC EVALUATION SHEET
AGE - FAMILY INCOME HOME - MARITAL STATUS
Figure 2. Phase 1 protocol steps.
Evaluaon of the heart rate variability with duraon of 45 minutes for group i and group ii
First moment - 15 minutes of rest: relaxed sing with heart rate monitoring
Second moment - 15 minutes of intervenon, divided into three sub groups of 5 minutes 
each, as follows:
First sub group: seizure 
acvies, handling jugs of 
water with glass and serving 
biscuits.
Second subgroup: locomotor 
acvity, walking between 
corridors and clinic rooms.
Third sub-group: ludic-
pedagogic acvies. 
Assembly of toy cubes.
Third moment: 15 minutes recovery, where the individual will be relaxed, resng in the
room.
Note: at the end of each subgroup, an evaluaon of Systolic bllod pressure (SBP), Diastolic 
Bllod pressure (DBP), HR and Glycemia.
Figure 3. Flowchart of phase 2 protocol steps.
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The HR monitoring for further analysis of HRV will be
obtained by an HR receptor RS800CX, Polar Electro, Finland.
This device was validated to locate the heart beat for HRV
analysis (Fig. 7). At the appropriate moment for collection during
the estimated 45minutes of evaluation, the strap will be placed on
the chest of volunteers and the HR receptor (Fig. 8), which is an
equipment previously validated for HR reception, beat and use
these data for HRV analysis. The receiver temporarily stores the
data that will then be processed on computers.
The recorded pulses will be directed to a computer through an
infrared signal emitting interface for analysis of theHRV by Polar
Precision Performance software. For data analysis, after storage
in the software, they will be filtered at a moderate intensity for the
elimination of ectopic beats and/or noises. The HRV analysis will
be performed in time and frequency domain (linear analysis) and
also by nonlinear analysis (Fig. 9).
Data collection of intervention in subjects of Group i,
temporary deprived of vision, will be performed individually,
on working days from 8:00 to 12:00 AM, recorded in a
standardized sheet (Annex 4). The venues will be discrete and
isolated, which could be in the outpatient or recreation/training
environment of CAP-AC and the CSO in Rio Branco.
2.8. Data analysis
Data will be analyzed using the Statistical Package for Social
Science, version 22.0. Descriptive analysis will be performed for
all variables. Data will be expressed as mean± standard deviation
or median (interquartile range), where appropriate. Sample
distribution will be tested with the Shapiro–Wilk test. For
comparison of initial and final values between groups, the
unpaired Student t test for parametric distributions and the
Mann–Whitney test for nonparametric distributions will be
applied. Statistical significance will be considered at the level of
P< .05 (or 5%).
As a risk measure, odds ratio will be calculated, adjusted, and
not adjusted with their respective 95% confidence intervals. The
odds ratio=1 of lowest risk for the outcome of interest will be
considered as the base category for each independent variable.
Statistically significant variables in the univariate analysis will
compose the model for the multivariate analysis. In this
multivariate analysis, multiple logistic regression will be used
(Fig. 10).
3. Discussion
Overall, in 2010, out of a total of 32.4 million blind and 191
million visually impaired, 0.8 million were blind and 3.7 million
were visually impaired because of diabetic retinopathy (DR), with
an alarming increase of 27% and 64%, respectively, in the 2
decades from 1990 to 2010. These numbers were lower in regions
with younger populations (<2% in Southeast Asia and Oceania)
than in high-income regions (North America, Western Europe,
and Asia) with populations relatively aged (>4%).[18]
Dyslipidemia and hypertension may also influence DR,











Figure 4. Team work.
Figure 5. Maximum occlusion.
Figure 6. Educational toys.
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between plasma lipids, lipoproteins, and DR are not strong
enough to define the risk of retinopathy. Similarly, hypertension
has been associated with increased risk of RD, and some data
indicate that patients may benefit from the use of antihypertensive
agents. However, recent studies have shown that more intensive
BP monitoring does not confer additional benefits on the
progression of retinopathy compared to standard follow-up.
Taken together, the optimization of systemic risk factors is clearly
important; however, even hyperglycemia (as measured by
HbA1c) may represent only about 10% of risk of DR, and
combined hypertension and dyslipidemia can lead to <10% risk
in some cohorts. Such data strongly suggest that additional
unidentified factors also play critical roles in the initiation and
progression of DR.[19]
Universality is linked to the guarantee of the right to the same
level of healthcare for all Brazilians, without any discrimination.
It is very relevant researching about better ways of achieving
positive results, new knowledge, and products that will improve
the health of the population, either with a new diagnosis or new
therapeutic treatments, or even with actions aimed at promoting
the health of the population.[20,21] The authors intend to propose
a good quality protocol in its execution, having patient safety and
demonstrating reliable information for healthcare area, contrib-
uting for better health care indicators of visually impaired people.
3.1. Declaration, ethics approval, and consent to
participate
This study will follow the guidelines that regulate human research
in Resolution No. 466/12 of the National Health Council. We
obtained approval from the Research Ethics Committee of
Faculdade de Medicina do ABC, with CAAE:
73945017.0.0000.0082, and Opinion No. 2,275,101. All
patients who agree to participate in the study will sign an
informed consent form (FICF). The FICF is also available in audio
and Braille versions. This study is registered in the Brazilian
Registry of Clinical Trials under the number RBR-9sm9dp.
Temporary deprivation of vision pretends to simulate a fleeting
“acute blindness” during 45 minutes to study the behavior of the
ANS acting in the human heart, without significant risks to the
participants andwithout waiting for natural events of sudden loss
of bilateral vision.
Information and data collected will remain available to the
participants in the archives of the institutions involved in the
research, during and after the closure of this study.
Figure 7. RS800CX, Polar Electro, Finland.
Figure 8. Placement of the belt on the patient.
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STUDY POPULATION 
Volunteers with normal vision Students and individuals with visual 
impairment
ELIGIBILITY CRITERIA 











COLLECTION INSTRUMENTS – 1ST PHASE 





15 MINUTES OF 
INTERVENTION – 
DIVIDED IN 3 
PERIODS OF 5 
MINUTES 
TIME 3: 






Figure 10. General protocol flowchart.
Figure 9. Data transfer.
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